22 results
8-K
EX-1.1
GLUE
Monte Rosa Therapeutics Inc
16 May 24
Monte Rosa Therapeutics Announces Pricing of $100 Million Underwritten Public Offering
4:06pm
) Medicare (Title XVIII of the Social Security Act); (v) Medicaid (Title XIX of the Social Security Act); and (vi) any and all other applicable health
S-3
EX-1.2
GLUE
Monte Rosa Therapeutics Inc
1 Jul 22
Shelf registration
5:01pm
and Clinical Health Act (42 U.S.C. Section 17921 et seq.), and the regulations promulgated pursuant to such statutes; (iii) Medicare (Title XVIII of the Social … Security Act); (iv) Medicaid (Title XIX of the Social Security Act); and (v) any and all other applicable health care laws and regulations. The Company
10-K
2021 FY
EX-10.20
GLUE
Monte Rosa Therapeutics Inc
29 Mar 22
Annual report
4:15pm
to that infected individual.
4. In Common Areas, including elevators and parking garages, individuals must wear face coverings or masks, practice social
10-K
uer9ovwik6oe
29 Mar 22
Annual report
4:15pm
10-Q
4oieyl6oz5m9yn
12 Aug 21
Quarterly report
4:22pm
S-8
EX-99.2
p1irnd nw7i5i8
25 Jun 21
Registration of securities for employees
4:03pm
424B4
3flp62
25 Jun 21
Prospectus supplement with pricing info
6:08am
S-1/A
8a6br3xlyk
9 Jun 21
IPO registration (amended)
4:51pm
S-1
EX-10.1
no48n6hg1v0q83c
4 Jun 21
IPO registration
9:07am
S-1
EX-4.2
2imxjrfk
4 Jun 21
IPO registration
9:07am
S-1
dlsr124ibe0
4 Jun 21
IPO registration
9:07am
DRS/A
r13e04sh k7
21 May 21
Draft registration statement (amended)
12:00am